Update on Business Immunity to COVID-19 Lawsuits

by Kenny Dolgin, Data Insights, Guidepoint Abiomed, Inc. (NYSE: ABMD) is a leader in the percutaneous heart pump device market, having launched its first Impella device in 2008 and have since released four iterations with varying flow rates. From May…

Read More

Update on Business Immunity to COVID-19 Lawsuits

  CLIENT SITUATION A healthcare team at a leading consulting firm wanted to better understand how anti-cancer pharmaceuticals are evaluated for inclusion on payer formularies. They were conducting strategy research on behalf of a pharmaceutical company. They needed a large…

Read More

Update on Business Immunity to COVID-19 Lawsuits

  CLIENT SITUATION A due diligence team at a leading consulting firm needed to quickly get up to speed on data center storage solutions. To better understand the major players and potential market size for these solutions, they were looking…

Read More

Update on Business Immunity to COVID-19 Lawsuits

by Alon Ben Joseph, CEO of Ace Jewelers Group   HOW DID CVC BEAT THE LUXURY GROUPS? In October 2016, rumors started that one of the few independent, family-owned and run watchmaking companies was for sale. Six months later, the…

Read More

Update on Business Immunity to COVID-19 Lawsuits

by Kenny Dolgin, Data Insights, Guidepoint Edwards Lifesciences Corp. (NYSE: EW) is a leader in the approximately $3 billion transcatheter heart valve (THV) market, having launched their first SAPIEN valve in the U.S. in 2011 and now having released their…

Read More

Update on Business Immunity to COVID-19 Lawsuits

By Michael P. Fischetti, Executive Director, National Contract Management Association Government contracting is as old as government itself. Two key factors: 1) reduced budgets and 2) more complex contracts, have forced government to learn more about supply chain learning.  …

Read More

Update on Business Immunity to COVID-19 Lawsuits

by Chris Slezakowski, Market Strategist Traditional in nature and highly manual in execution, construction is perhaps one of the last industries to feel the impact of the digital revolution. Aerospace, automotive, industrial manufacturing, banking and finance; these and other sectors…

Read More

Update on Business Immunity to COVID-19 Lawsuits

  CLIENT SITUATION A team at a leading management consulting firm was working on a tight timeline to better understand trends in Pharmacy Benefit Managers (PBMs). They were conducting competitive analysis within marketing divisions evaluation to identify potential savings. They…

Read More

Update on Business Immunity to COVID-19 Lawsuits

by Kenny Dolgin, Data Insights, Guidepoint Penumbra Inc. (NYSE: PEN) is a key player in the treatment for ischemic stroke, having received FDA approval for the first aspiration-based thrombectomy system in 2007 and having since launched five new generations of…

Read More

Update on Business Immunity to COVID-19 Lawsuits

  CLIENT SITUATION A consulting team was just staffed on a PE due diligence project and needed to answer the question: “At what rate is business shifting to the cloud?”   GUIDEPOINT SOLUTION Guidepoint quickly vetted over 200 industry experts,…

Read More